Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Communication Strategy for Families of Patients Dying in the ICU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00331877
Recruitment Status : Terminated
First Posted : May 31, 2006
Last Update Posted : May 31, 2006
Sponsor:
Information provided by:
Famirea Study Group

Brief Summary:
Decisions to limit life sustaining treatments are made for most patients dying in the ICU, usually with input from the family. The well-being of the family may be jeopardized by involvement in the decision-making process and bereavement. We evaluated the ability of a proactive communication strategy (family conference and providing family members with a bereavement information leaflet) designed to improve family well-being.

Condition or disease Intervention/treatment Phase
Family of Dying Patient in the ICU Procedure: family conference with bereavement information leaflet Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 136 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Educational/Counseling/Training
Official Title: A Proactive Communication Strategy for Family Members of Patients Dying in the ICU: A Multicenter Randomized Controlled Trial
Study Start Date : May 2005
Study Completion Date : January 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bereavement




Primary Outcome Measures :
  1. symptoms related to posttraumatic stress disorder

Secondary Outcome Measures :
  1. symptoms of anxiety and depression


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • family of dying patient

Exclusion Criteria:

  • family having no enough knowledge of French to respond to telephone interview
  • patient alive on day 90

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00331877


Sponsors and Collaborators
Famirea Study Group
Investigators
Layout table for investigator information
Study Director: Elie Azoulay, Md, PhD Famirea Study Group
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00331877    
Other Study ID Numbers: famirea VIII
First Posted: May 31, 2006    Key Record Dates
Last Update Posted: May 31, 2006
Last Verified: May 2006
Keywords provided by Famirea Study Group:
family
end-of-life
intensive care unit